From the Halifax Chronicle Herald:
The Canadian launch this week of a new medication that prevents HIV from entering fresh cells will help many people living with the virus, says a Halifax infectious diseases specialist.
Dr. David Haase said Tuesday that maraviroc, brand-named Celsentri, is a new class of drug that’s taken in tablet form. It’s been approved by Health Canada and was introduced into the marketplace Monday.
Maraviroc prevents entry of HIV "into the cells that usually infect the white blood cells," said Dr. Haase of the Queen Elizabeth II Health Sciences Centre. ...more
Showing posts with label Celsentri. Show all posts
Showing posts with label Celsentri. Show all posts
Thursday, October 18, 2007
Wednesday, October 17, 2007
New drug approved in Canada to treat HIV, first in 10 years
From the Canadian Press:
Health Canada has approved the first drug in the first new class of HIV medications to be brought to market in Canada in a decade.
Celsentri - the brand name for the drug maraviroc - is the first of a class of drugs called CCR5 antagonists to gain regulatory approval.
The drug, made by Pfizer Canada Inc., blocks entry of HIV into the immune system's T cells, reducing the level of the virus in the body. It is approved for use only in people who have already been on other HIV medications; it is not licensed for people who are just starting anti-retroviral drug therapy. ...more
Health Canada has approved the first drug in the first new class of HIV medications to be brought to market in Canada in a decade.
Celsentri - the brand name for the drug maraviroc - is the first of a class of drugs called CCR5 antagonists to gain regulatory approval.
The drug, made by Pfizer Canada Inc., blocks entry of HIV into the immune system's T cells, reducing the level of the virus in the body. It is approved for use only in people who have already been on other HIV medications; it is not licensed for people who are just starting anti-retroviral drug therapy. ...more
Subscribe to:
Posts (Atom)